Literature DB >> 26092819

Interpreting quality-of-life data from the SOFT and TEXT trials.

Rowan T Chlebowski1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26092819     DOI： 10.1016/S1470-2045(15)00052-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.

Authors:  Kathy Pan; Rowan T Chlebowski; Michael S Simon; Roberta M Ray; Jennifer Livaudais-Toman; Shannon D Sullivan; Marcia L Stefanick; Robert B Wallace; Meryl LeBoff; Elizabeth Carhart Bluhm; Electra D Paskett
Journal:  Breast Cancer Res Treat       Date:  2016-04-13       Impact factor: 4.872

2.  Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.

Authors:  Teresa C O Tsui; Maureen Trudeau; Nicholas Mitsakakis; Sofia Torres; Karen E Bremner; Doyoung Kim; Aileen M Davis; Murray D Krahn
Journal:  PLoS One       Date:  2022-02-04       Impact factor: 3.240

Review 3.  Endocrine Therapy in Early Breast Cancer.

Authors:  Katja Krauss; Elmar Stickeler
Journal:  Breast Care (Basel)       Date:  2020-07-21       Impact factor: 2.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.